Clinical Trial Update: Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hepatic arterial infusion chemotherapy in combination with Adebrelimab and Bevacizumab for potentially resectable hepatocellul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Bevacizumab (bevacizumab)
• Hepatic arterial infusion chemotherapy (HAIC) (hepatic arterial infusion chemotherapy)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Adebrelimab, Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING